Latest Quarter
Q2 FY2026ended 2026-06-30 ยท filed 2026-07-28
$164.2M
$-1.16B
$-78.47M
-$3.32
$1.77B
$5.26B
$-2.42B
$4.3B
What this quarter tells us
For Q1 FY2026 ended March 31, 2026, Core Scientific reported revenue of $115.2 million, up 44.9% year-over-year. Net loss was $347.2 million, compared to a loss of $133.2 million in the prior year quarter. Operating loss widened to $310.4 million from $47.0 million. Diluted EPS was -$1.06, down from -$0.37.
- โขRevenue increased 44.9% YoY to $115.2 million.
- โขNet loss widened to $347.2 million from $133.2 million.
- โขOperating loss expanded to $310.4 million from $47.0 million.
- โขDiluted EPS was -$1.06, compared to -$0.37 in Q1 FY2025.
Informational summary based on SEC XBRL figures ยท generated by deepseek-v4-flash. Not investment advice.